<?xml version="1.0" ?>
<!DOCTYPE PubmedArticleSet PUBLIC "-//NLM//DTD PubMedArticle, 1st January 2023//EN" "https://dtd.nlm.nih.gov/ncbi/pubmed/out/pubmed_230101.dtd">
<PubmedArticleSet>
<PubmedArticle><MedlineCitation Status="MEDLINE" Owner="NLM"><PMID Version="1">34910152</PMID><DateCompleted><Year>2022</Year><Month>01</Month><Day>13</Day></DateCompleted><DateRevised><Year>2023</Year><Month>08</Month><Day>16</Day></DateRevised><Article PubModel="Electronic"><Journal><ISSN IssnType="Electronic">2574-3805</ISSN><JournalIssue CitedMedium="Internet"><Volume>4</Volume><Issue>12</Issue><PubDate><Year>2021</Year><Month>Dec</Month><Day>01</Day></PubDate></JournalIssue><Title>JAMA network open</Title><ISOAbbreviation>JAMA Netw Open</ISOAbbreviation></Journal><ArticleTitle>Incidence of and Mortality From Amyotrophic Lateral Sclerosis in National Football League Athletes.</ArticleTitle><Pagination><StartPage>e2138801</StartPage><MedlinePgn>e2138801</MedlinePgn></Pagination><ELocationID EIdType="pii" ValidYN="Y">e2138801</ELocationID><ELocationID EIdType="doi" ValidYN="Y">10.1001/jamanetworkopen.2021.38801</ELocationID><Abstract><AbstractText Label="IMPORTANCE">Amyotrophic lateral sclerosis (ALS) is a fatal neurodegenerative disease; understanding ALS risk factors is a critical public health issue.</AbstractText><AbstractText Label="OBJECTIVES">To evaluate the incidence of and mortality from ALS in National Football League (NFL) athletes and to describe characteristics associated with ALS within this cohort.</AbstractText><AbstractText Label="DESIGN, SETTING, AND PARTICIPANTS">This population-based cohort study included all 19&#x202f;423 NFL athletes who debuted between 1960 and 2019 and played 1 or more professional game. It was conducted between October 3, 2020, and July 19, 2021.</AbstractText><AbstractText Label="EXPOSURE">Participation in the NFL, including playing 1 or more professional games.</AbstractText><AbstractText Label="MAIN OUTCOMES AND MEASURES">Cases of ALS and death information were identified based on public records from NFL statistics aggregators, news reports, obituaries, and National Death Index results. The standardized incidence ratio and the standardized mortality ratio were calculated based on data acquired from surveillance studies of ALS accounting for age, sex, and race. Secondary analyses examined the association of body mass index, NFL career duration, race, birth location, and markers of fame, using a nested case-control design, matching athletes with ALS to athletes without ALS, by NFL debut year.</AbstractText><AbstractText Label="RESULTS">A total of 19&#x202f;423 male former and current NFL players (age range, 23-78 years) were included in this cohort study and were followed up for a cumulative 493&#x202f;168 years (mean [SD] follow-up, 30.6 [13.7] years). Thirty-eight players received a diagnosis of ALS, and 28 died during the study time frame, representing a significantly higher incidence of ALS diagnosis (standardized incidence ratio, 3.59; 95% CI, 2.58-4.93) and mortality (standardized mortality ratio, 3.94; 95% CI, 2.62-5.69) among NFL players compared with the US male population, adjusting for age and race. Among NFL athletes, nested-case-control analyses found that those who received a diagnosis of ALS had significantly longer careers (mean [SD] duration, 7.0 [3.9] years) than athletes without ALS (mean [SD] duration, 4.5 [3.6] years; odds ratio, 1.2; 95% CI, 1.1-1.3). There were no differences in ALS status based on proxies of NFL fame, body mass index, position played, birth location, or race.</AbstractText><AbstractText Label="CONCLUSIONS AND RELEVANCE">The age-, sex-, and race-adjusted incidence of and mortality from ALS among all NFL players who debuted between 1960 and 2019 were nearly 4 times as high as those of the general population. Athletes with a diagnosis of ALS had longer NFL careers than those without ALS, suggesting an association between NFL duration of play and ALS. The identification of these risk factors for ALS helps to inform the study of pathophysiological mechanisms responsible for this fatal neurodegenerative disease.</AbstractText></Abstract><AuthorList CompleteYN="Y"><Author ValidYN="Y"><LastName>Daneshvar</LastName><ForeName>Daniel H</ForeName><Initials>DH</Initials><AffiliationInfo><Affiliation>Department of Physical Medicine and Rehabilitation, Harvard Medical School, Boston, Massachusetts.</Affiliation></AffiliationInfo><AffiliationInfo><Affiliation>Department of Physical Medicine and Rehabilitation, Massachusetts General Hospital, Boston.</Affiliation></AffiliationInfo><AffiliationInfo><Affiliation>Department of Physical Medicine and Rehabilitation, Spaulding Rehabilitation Hospital, Boston, Massachusetts.</Affiliation></AffiliationInfo><AffiliationInfo><Affiliation>Boston University Alzheimer's Disease and CTE Centers, Boston University School of Medicine, Boston, Massachusetts.</Affiliation></AffiliationInfo></Author><Author ValidYN="Y"><LastName>Mez</LastName><ForeName>Jesse</ForeName><Initials>J</Initials><AffiliationInfo><Affiliation>Boston University Alzheimer's Disease and CTE Centers, Boston University School of Medicine, Boston, Massachusetts.</Affiliation></AffiliationInfo><AffiliationInfo><Affiliation>Department of Neurology, Boston University School of Medicine, Boston, Massachusetts.</Affiliation></AffiliationInfo><AffiliationInfo><Affiliation>Framingham Heart Study, Boston University School of Medicine, Boston, Massachusetts.</Affiliation></AffiliationInfo></Author><Author ValidYN="Y"><LastName>Alosco</LastName><ForeName>Michael L</ForeName><Initials>ML</Initials><AffiliationInfo><Affiliation>Boston University Alzheimer's Disease and CTE Centers, Boston University School of Medicine, Boston, Massachusetts.</Affiliation></AffiliationInfo><AffiliationInfo><Affiliation>Department of Neurology, Boston University School of Medicine, Boston, Massachusetts.</Affiliation></AffiliationInfo></Author><Author ValidYN="Y"><LastName>Baucom</LastName><ForeName>Zachary H</ForeName><Initials>ZH</Initials><AffiliationInfo><Affiliation>Boston University Alzheimer's Disease and CTE Centers, Boston University School of Medicine, Boston, Massachusetts.</Affiliation></AffiliationInfo><AffiliationInfo><Affiliation>Department of Biostatistics, Boston University School of Public Health, Boston, Massachusetts.</Affiliation></AffiliationInfo></Author><Author ValidYN="Y"><LastName>Mahar</LastName><ForeName>Ian</ForeName><Initials>I</Initials><AffiliationInfo><Affiliation>Boston University Alzheimer's Disease and CTE Centers, Boston University School of Medicine, Boston, Massachusetts.</Affiliation></AffiliationInfo><AffiliationInfo><Affiliation>Department of Neurology, Boston University School of Medicine, Boston, Massachusetts.</Affiliation></AffiliationInfo></Author><Author ValidYN="Y"><LastName>Baugh</LastName><ForeName>Christine M</ForeName><Initials>CM</Initials><AffiliationInfo><Affiliation>Center for Bioethics and Humanities, University of Colorado Denver Anschutz Medical Campus, Aurora.</Affiliation></AffiliationInfo><AffiliationInfo><Affiliation>Division of General Internal Medicine, University of Colorado School of Medicine, Aurora.</Affiliation></AffiliationInfo></Author><Author ValidYN="Y"><LastName>Valle</LastName><ForeName>Jhaqueline P</ForeName><Initials>JP</Initials><AffiliationInfo><Affiliation>Public Health Institute, California Department of Public Health, Richmond.</Affiliation></AffiliationInfo></Author><Author ValidYN="Y"><LastName>Weuve</LastName><ForeName>Jennifer</ForeName><Initials>J</Initials><AffiliationInfo><Affiliation>Department of Epidemiology, Boston University School of Public Health, Boston, Massachusetts.</Affiliation></AffiliationInfo></Author><Author ValidYN="Y"><LastName>Paganoni</LastName><ForeName>Sabrina</ForeName><Initials>S</Initials><AffiliationInfo><Affiliation>Department of Physical Medicine and Rehabilitation, Harvard Medical School, Boston, Massachusetts.</Affiliation></AffiliationInfo><AffiliationInfo><Affiliation>Department of Physical Medicine and Rehabilitation, Massachusetts General Hospital, Boston.</Affiliation></AffiliationInfo><AffiliationInfo><Affiliation>Department of Physical Medicine and Rehabilitation, Spaulding Rehabilitation Hospital, Boston, Massachusetts.</Affiliation></AffiliationInfo><AffiliationInfo><Affiliation>Sean M Healey &amp; AMG Center for ALS, Department of Neurology, Massachusetts General Hospital, Boston.</Affiliation></AffiliationInfo></Author><Author ValidYN="Y"><LastName>Cantu</LastName><ForeName>Robert C</ForeName><Initials>RC</Initials><AffiliationInfo><Affiliation>Boston University Alzheimer's Disease and CTE Centers, Boston University School of Medicine, Boston, Massachusetts.</Affiliation></AffiliationInfo><AffiliationInfo><Affiliation>Department of Neurology, Boston University School of Medicine, Boston, Massachusetts.</Affiliation></AffiliationInfo><AffiliationInfo><Affiliation>Department of Neurosurgery, Boston University School of Medicine, Boston, Massachusetts.</Affiliation></AffiliationInfo><AffiliationInfo><Affiliation>Department of Neurosurgery, Emerson Hospital, Concord, Massachusetts.</Affiliation></AffiliationInfo><AffiliationInfo><Affiliation>Concussion Legacy Foundation, Boston, Massachusetts.</Affiliation></AffiliationInfo></Author><Author ValidYN="Y"><LastName>Zafonte</LastName><ForeName>Ross D</ForeName><Initials>RD</Initials><AffiliationInfo><Affiliation>Department of Physical Medicine and Rehabilitation, Harvard Medical School, Boston, Massachusetts.</Affiliation></AffiliationInfo><AffiliationInfo><Affiliation>Department of Physical Medicine and Rehabilitation, Massachusetts General Hospital, Boston.</Affiliation></AffiliationInfo><AffiliationInfo><Affiliation>Department of Physical Medicine and Rehabilitation, Spaulding Rehabilitation Hospital, Boston, Massachusetts.</Affiliation></AffiliationInfo><AffiliationInfo><Affiliation>Department of Physical Medicine and Rehabilitation, Brigham and Women's Hospital, Boston, Massachusetts.</Affiliation></AffiliationInfo></Author><Author ValidYN="Y"><LastName>Stern</LastName><ForeName>Robert A</ForeName><Initials>RA</Initials><AffiliationInfo><Affiliation>Boston University Alzheimer's Disease and CTE Centers, Boston University School of Medicine, Boston, Massachusetts.</Affiliation></AffiliationInfo><AffiliationInfo><Affiliation>Department of Neurology, Boston University School of Medicine, Boston, Massachusetts.</Affiliation></AffiliationInfo><AffiliationInfo><Affiliation>Department of Neurosurgery, Boston University School of Medicine, Boston, Massachusetts.</Affiliation></AffiliationInfo><AffiliationInfo><Affiliation>Department of Anatomy &amp; Neurobiology, Boston University School of Medicine, Boston, Massachusetts.</Affiliation></AffiliationInfo></Author><Author ValidYN="Y"><LastName>Stein</LastName><ForeName>Thor D</ForeName><Initials>TD</Initials><AffiliationInfo><Affiliation>Department of Physical Medicine and Rehabilitation, Harvard Medical School, Boston, Massachusetts.</Affiliation></AffiliationInfo><AffiliationInfo><Affiliation>Veterans Affairs Boston Healthcare System, Department of Veterans Affairs, Boston, Massachusetts.</Affiliation></AffiliationInfo><AffiliationInfo><Affiliation>Department of Veterans Affairs Medical Center, Bedford, Massachusetts.</Affiliation></AffiliationInfo><AffiliationInfo><Affiliation>Department of Pathology and Laboratory Medicine, Boston University School of Medicine, Boston, Massachusetts.</Affiliation></AffiliationInfo></Author><Author ValidYN="Y"><LastName>Tripodis</LastName><ForeName>Yorghos</ForeName><Initials>Y</Initials><AffiliationInfo><Affiliation>Boston University Alzheimer's Disease and CTE Centers, Boston University School of Medicine, Boston, Massachusetts.</Affiliation></AffiliationInfo><AffiliationInfo><Affiliation>Department of Biostatistics, Boston University School of Public Health, Boston, Massachusetts.</Affiliation></AffiliationInfo></Author><Author ValidYN="Y"><LastName>Nowinski</LastName><ForeName>Christopher J</ForeName><Initials>CJ</Initials><AffiliationInfo><Affiliation>Boston University Alzheimer's Disease and CTE Centers, Boston University School of Medicine, Boston, Massachusetts.</Affiliation></AffiliationInfo><AffiliationInfo><Affiliation>Department of Neurosurgery, Emerson Hospital, Concord, Massachusetts.</Affiliation></AffiliationInfo></Author><Author ValidYN="Y"><LastName>McKee</LastName><ForeName>Ann C</ForeName><Initials>AC</Initials><AffiliationInfo><Affiliation>Boston University Alzheimer's Disease and CTE Centers, Boston University School of Medicine, Boston, Massachusetts.</Affiliation></AffiliationInfo><AffiliationInfo><Affiliation>Department of Neurology, Boston University School of Medicine, Boston, Massachusetts.</Affiliation></AffiliationInfo><AffiliationInfo><Affiliation>Framingham Heart Study, Boston University School of Medicine, Boston, Massachusetts.</Affiliation></AffiliationInfo><AffiliationInfo><Affiliation>Veterans Affairs Boston Healthcare System, Department of Veterans Affairs, Boston, Massachusetts.</Affiliation></AffiliationInfo><AffiliationInfo><Affiliation>Department of Veterans Affairs Medical Center, Bedford, Massachusetts.</Affiliation></AffiliationInfo><AffiliationInfo><Affiliation>Department of Pathology and Laboratory Medicine, Boston University School of Medicine, Boston, Massachusetts.</Affiliation></AffiliationInfo></Author></AuthorList><Language>eng</Language><GrantList CompleteYN="Y"><Grant><GrantID>I01 BX005161</GrantID><Acronym>BX</Acronym><Agency>BLRD VA</Agency><Country>United States</Country></Grant><Grant><GrantID>K23 NS102399</GrantID><Acronym>NS</Acronym><Agency>NINDS NIH HHS</Agency><Country>United States</Country></Grant><Grant><GrantID>RF1 AG057902</GrantID><Acronym>AG</Acronym><Agency>NIA NIH HHS</Agency><Country>United States</Country></Grant></GrantList><PublicationTypeList><PublicationType UI="D016428">Journal Article</PublicationType><PublicationType UI="D064888">Observational Study</PublicationType><PublicationType UI="D052061">Research Support, N.I.H., Extramural</PublicationType><PublicationType UI="D013485">Research Support, Non-U.S. Gov't</PublicationType><PublicationType UI="D013486">Research Support, U.S. Gov't, Non-P.H.S.</PublicationType></PublicationTypeList><ArticleDate DateType="Electronic"><Year>2021</Year><Month>12</Month><Day>01</Day></ArticleDate></Article><MedlineJournalInfo><Country>United States</Country><MedlineTA>JAMA Netw Open</MedlineTA><NlmUniqueID>101729235</NlmUniqueID><ISSNLinking>2574-3805</ISSNLinking></MedlineJournalInfo><CitationSubset>IM</CitationSubset><MeshHeadingList><MeshHeading><DescriptorName UI="D000328" MajorTopicYN="N">Adult</DescriptorName></MeshHeading><MeshHeading><DescriptorName UI="D000368" MajorTopicYN="N">Aged</DescriptorName></MeshHeading><MeshHeading><DescriptorName UI="D000690" MajorTopicYN="N">Amyotrophic Lateral Sclerosis</DescriptorName><QualifierName UI="Q000453" MajorTopicYN="N">epidemiology</QualifierName><QualifierName UI="Q000209" MajorTopicYN="Y">etiology</QualifierName></MeshHeading><MeshHeading><DescriptorName UI="D056352" MajorTopicYN="Y">Athletes</DescriptorName></MeshHeading><MeshHeading><DescriptorName UI="D001265" MajorTopicYN="N">Athletic Injuries</DescriptorName><QualifierName UI="Q000150" MajorTopicYN="N">complications</QualifierName></MeshHeading><MeshHeading><DescriptorName UI="D016022" MajorTopicYN="N">Case-Control Studies</DescriptorName></MeshHeading><MeshHeading><DescriptorName UI="D006259" MajorTopicYN="N">Craniocerebral Trauma</DescriptorName><QualifierName UI="Q000150" MajorTopicYN="N">complications</QualifierName></MeshHeading><MeshHeading><DescriptorName UI="D005500" MajorTopicYN="N">Follow-Up Studies</DescriptorName></MeshHeading><MeshHeading><DescriptorName UI="D005538" MajorTopicYN="Y">Football</DescriptorName><QualifierName UI="Q000293" MajorTopicYN="N">injuries</QualifierName></MeshHeading><MeshHeading><DescriptorName UI="D006801" MajorTopicYN="N">Humans</DescriptorName></MeshHeading><MeshHeading><DescriptorName UI="D015994" MajorTopicYN="N">Incidence</DescriptorName></MeshHeading><MeshHeading><DescriptorName UI="D016015" MajorTopicYN="N">Logistic Models</DescriptorName></MeshHeading><MeshHeading><DescriptorName UI="D008297" MajorTopicYN="N">Male</DescriptorName></MeshHeading><MeshHeading><DescriptorName UI="D008875" MajorTopicYN="N">Middle Aged</DescriptorName></MeshHeading><MeshHeading><DescriptorName UI="D016017" MajorTopicYN="N">Odds Ratio</DescriptorName></MeshHeading><MeshHeading><DescriptorName UI="D012189" MajorTopicYN="N">Retrospective Studies</DescriptorName></MeshHeading><MeshHeading><DescriptorName UI="D012307" MajorTopicYN="N">Risk Factors</DescriptorName></MeshHeading><MeshHeading><DescriptorName UI="D014481" MajorTopicYN="N" Type="Geographic">United States</DescriptorName><QualifierName UI="Q000453" MajorTopicYN="N">epidemiology</QualifierName></MeshHeading></MeshHeadingList><CoiStatement><b>Conflict of Interest Disclosures:</b> Dr Mez reported receiving grants from the National Institutes of Health (NIH)/National Institute on Aging (NIA)/National Institute of Neurological Disorders and Stroke (NINDS) during the conduct of the study. Dr Alosco reported receiving royalties from Oxford University Press outside the submitted work; and grants from the NIH. Dr Baugh reported receiving grants from Datalys Center for Sports Injury Research and Prevention and personal fees from the University of Connecticut (funded by a grant from the National Football Leauge [NFL] Foundation) for serving as a consultant on a concussion legislation project with the University of Connecticut, outside the submitted work. Dr Paganoni reported receiving grants from Amylyx, Revalesio, Clene, Prilenia, UCB, Seelos, and Biohaven; and personal fees from Orion and Cytokinetics outside the submitted work. Dr Cantu reported serving as senior advisor to the NFL Head, Neck and Spine Committee; serving as vice president of National Operating Committee on Standards for Athletic Equipment and chair of the scientific advisory committee for National Operating Committee on Standards for Athletic Equipment; being co-founder and medical director of the Concussion Legacy Foundation; receiving royalties from Houghton Mifflin Harcourt; and providing legal expert opinion (eg, the National Collegiate Athletic Association [NCAA] and the National Hockey League). Dr Zafonte reported receiving royalties from Springer/Demos Publishing for serving as co-editor of the text <i>Brain Injury Medicine</i>; serving on the scientific advisory board of Myomo, and onecare.ai; and evaluating patients in the Massachusetts General Hospital Brain and Body-Trust Program, which is funded by the NFL Players Association. Dr Stern reported receiving grants from the NIH during the conduct of the study; personal fees from Biogen and Eli Lilly; and stock options as a member of the board of directors from King-Devick Technologies outside the submitted work; and is a member of Medical Science Committee of the NCAA Student-Athlete Concussion Injury Litigation and a member of the Mackey-White Health and Safety Committee, NFL Players Association; in addition, Dr Stern had a patent with royalties paid from Psychological Assessment Resources Inc for published neuropsychological tests. Dr Nowinski reported receiving travel support from the NFL Players Association; being a member of the NFL Players Association Mackey-White Health and Safety Committee; and holding options in Oxeia Biopharmaceuticals and PreCon Health outside the submitted work. No other disclosures were reported.</CoiStatement></MedlineCitation><PubmedData><History><PubMedPubDate PubStatus="entrez"><Year>2021</Year><Month>12</Month><Day>15</Day><Hour>12</Hour><Minute>42</Minute></PubMedPubDate><PubMedPubDate PubStatus="pubmed"><Year>2021</Year><Month>12</Month><Day>16</Day><Hour>6</Hour><Minute>0</Minute></PubMedPubDate><PubMedPubDate PubStatus="medline"><Year>2022</Year><Month>1</Month><Day>14</Day><Hour>6</Hour><Minute>0</Minute></PubMedPubDate></History><PublicationStatus>epublish</PublicationStatus><ArticleIdList><ArticleId IdType="pubmed">34910152</ArticleId><ArticleId IdType="pmc">PMC8674746</ArticleId><ArticleId IdType="doi">10.1001/jamanetworkopen.2021.38801</ArticleId><ArticleId IdType="pii">2787180</ArticleId></ArticleIdList><ReferenceList><Reference><Citation>Kiernan MC, Vucic S, Cheah BC, et al. . Amyotrophic lateral sclerosis. Lancet. 2011;377(9769):942-955. doi:10.1016/S0140-6736(10)61156-7</Citation><ArticleIdList><ArticleId IdType="doi">10.1016/S0140-6736(10)61156-7</ArticleId><ArticleId IdType="pubmed">21296405</ArticleId></ArticleIdList></Reference><Reference><Citation>Valle J, Roberts E, Paulukonis S, Collins N, English P, Kaye W. Epidemiology and surveillance of amyotrophic lateral sclerosis in two large metropolitan areas in California. Amyotroph Lateral Scler Frontotemporal Degener. 2015;16(3-4):209-215. doi:10.3109/21678421.2015.1019516</Citation><ArticleIdList><ArticleId IdType="doi">10.3109/21678421.2015.1019516</ArticleId><ArticleId IdType="pmc">PMC4544858</ArticleId><ArticleId IdType="pubmed">25822003</ArticleId></ArticleIdList></Reference><Reference><Citation>Rechtman L, Jordan H, Wagner L, Horton DK, Kaye W. Racial and ethnic differences among amyotrophic lateral sclerosis cases in the United States. Amyotroph Lateral Scler Frontotemporal Degener. 2015;16(1-2):65-71. doi:10.3109/21678421.2014.971813</Citation><ArticleIdList><ArticleId IdType="doi">10.3109/21678421.2014.971813</ArticleId><ArticleId IdType="pmc">PMC4389704</ArticleId><ArticleId IdType="pubmed">25482100</ArticleId></ArticleIdList></Reference><Reference><Citation>Harper CJ, Sorenson EJ, Mandrekar J. Epidemiology of amyotrophic lateral sclerosis in Minnesota: a year-long population based study. Amyotroph Lateral Scler Frontotemporal Degener. 2015;16(7-8):520-523. doi:10.3109/21678421.2015.1051991</Citation><ArticleIdList><ArticleId IdType="doi">10.3109/21678421.2015.1051991</ArticleId><ArticleId IdType="pubmed">26083871</ArticleId></ArticleIdList></Reference><Reference><Citation>Jordan H, Rechtman L, Wagner L, Kaye WE. Amyotrophic lateral sclerosis surveillance in Baltimore and Philadelphia. Muscle Nerve. 2015;51(6):815-821. doi:10.1002/mus.24488</Citation><ArticleIdList><ArticleId IdType="doi">10.1002/mus.24488</ArticleId><ArticleId IdType="pmc">PMC4535347</ArticleId><ArticleId IdType="pubmed">25298019</ArticleId></ArticleIdList></Reference><Reference><Citation>Freer C, Hylton T, Jordan HM, Kaye WE, Singh S, Huang Y. Results of Florida&#x2019;s Amyotrophic Lateral Sclerosis Surveillance Project, 2009-2011. BMJ Open. 2015;5(4):e007359. doi:10.1136/bmjopen-2014-007359</Citation><ArticleIdList><ArticleId IdType="doi">10.1136/bmjopen-2014-007359</ArticleId><ArticleId IdType="pmc">PMC4410133</ArticleId><ArticleId IdType="pubmed">25900464</ArticleId></ArticleIdList></Reference><Reference><Citation>Punjani R, Wagner L, Horton K, Kaye W. Atlanta metropolitan area amyotrophic lateral sclerosis (ALS) surveillance: incidence and prevalence 2009-2011 and survival characteristics through 2015. Amyotroph Lateral Scler Frontotemporal Degener. 2020;21(1-2):123-130. doi:10.1080/21678421.2019.1682614</Citation><ArticleIdList><ArticleId IdType="doi">10.1080/21678421.2019.1682614</ArticleId><ArticleId IdType="pmc">PMC8130365</ArticleId><ArticleId IdType="pubmed">31795746</ArticleId></ArticleIdList></Reference><Reference><Citation>Wagner L, Rechtman L, Jordan H, et al. . State and metropolitan area-based amyotrophic lateral sclerosis (ALS) surveillance. Amyotroph Lateral Scler Frontotemporal Degener. 2015;17(1-2):128-134. doi:10.3109/21678421.2015.1074699</Citation><ArticleIdList><ArticleId IdType="doi">10.3109/21678421.2015.1074699</ArticleId><ArticleId IdType="pmc">PMC4732418</ArticleId><ArticleId IdType="pubmed">26399278</ArticleId></ArticleIdList></Reference><Reference><Citation>Larson TC, Kaye W, Mehta P, Horton DK. Amyotrophic lateral sclerosis mortality in the United States, 2011-2014. Neuroepidemiology. 2018;51(1-2):96-103. doi:10.1159/000488891</Citation><ArticleIdList><ArticleId IdType="doi">10.1159/000488891</ArticleId><ArticleId IdType="pmc">PMC6159829</ArticleId><ArticleId IdType="pubmed">29990963</ArticleId></ArticleIdList></Reference><Reference><Citation>Nguyen VT, Zafonte RD, Chen JT, et al. . Mortality among professional American-style football players and professional American baseball players. JAMA Netw Open. 2019;2(5):e194223. doi:10.1001/jamanetworkopen.2019.4223</Citation><ArticleIdList><ArticleId IdType="doi">10.1001/jamanetworkopen.2019.4223</ArticleId><ArticleId IdType="pmc">PMC6632140</ArticleId><ArticleId IdType="pubmed">31125098</ArticleId></ArticleIdList></Reference><Reference><Citation>Chen H, Richard M, Sandler DP, Umbach DM, Kamel F. Head injury and amyotrophic lateral sclerosis. Am J Epidemiol. 2007;166(7):810-816. doi:10.1093/aje/kwm153</Citation><ArticleIdList><ArticleId IdType="doi">10.1093/aje/kwm153</ArticleId><ArticleId IdType="pmc">PMC2239342</ArticleId><ArticleId IdType="pubmed">17641152</ArticleId></ArticleIdList></Reference><Reference><Citation>Schmidt S, Kwee LC, Allen KD, Oddone EZ. Association of ALS with head injury, cigarette smoking and APOE genotypes. J Neurol Sci. 2010;291(1-2):22-29. doi:10.1016/j.jns.2010.01.011</Citation><ArticleIdList><ArticleId IdType="doi">10.1016/j.jns.2010.01.011</ArticleId><ArticleId IdType="pmc">PMC2840700</ArticleId><ArticleId IdType="pubmed">20129626</ArticleId></ArticleIdList></Reference><Reference><Citation>McKee AC, Gavett BE, Stern RA, et al. . TDP-43 proteinopathy and motor neuron disease in chronic traumatic encephalopathy. J Neuropathol Exp Neurol. 2010;69(9):918-929. doi:10.1097/NEN.0b013e3181ee7d85</Citation><ArticleIdList><ArticleId IdType="doi">10.1097/NEN.0b013e3181ee7d85</ArticleId><ArticleId IdType="pmc">PMC2951281</ArticleId><ArticleId IdType="pubmed">20720505</ArticleId></ArticleIdList></Reference><Reference><Citation>Walt GS, Burris HM, Brady CB, et al. . Chronic traumatic encephalopathy within an amyotrophic lateral sclerosis Brain Bank cohort. J Neuropathol Exp Neurol. 2018;77(12):1091-1100. doi:10.1093/jnen/nly092</Citation><ArticleIdList><ArticleId IdType="doi">10.1093/jnen/nly092</ArticleId><ArticleId IdType="pmc">PMC6927868</ArticleId><ArticleId IdType="pubmed">30299493</ArticleId></ArticleIdList></Reference><Reference><Citation>Lehman EJ, Hein MJ, Baron SL, Gersic CM. Neurodegenerative causes of death among retired National Football League players. Neurology. 2012;79(19):1970-1974. doi:10.1212/WNL.0b013e31826daf50</Citation><ArticleIdList><ArticleId IdType="doi">10.1212/WNL.0b013e31826daf50</ArticleId><ArticleId IdType="pmc">PMC4098841</ArticleId><ArticleId IdType="pubmed">22955124</ArticleId></ArticleIdList></Reference><Reference><Citation>Mackay DF, Russell ER, Stewart K, MacLean JA, Pell JP, Stewart W. Neurodegenerative disease mortality among former professional soccer players. N Engl J Med. 2019;381(19):1801-1808. doi:10.1056/NEJMoa1908483</Citation><ArticleIdList><ArticleId IdType="doi">10.1056/NEJMoa1908483</ArticleId><ArticleId IdType="pubmed">31633894</ArticleId></ArticleIdList></Reference><Reference><Citation>Keim J. With average NFL career 3.3 years, players motivated to complete MBA program. ESPN. July 29, 2016. Accessed April 6, 2021. https://www.espn.com/blog/nflnation/post/_/id/207780/current-and-former-nfl-players-in-the-drivers-seat-after-completing-mba-program</Citation></Reference><Reference><Citation>Nakken O, Meyer HE, Stigum H, Holm&#xf8;y T. High BMI is associated with low ALS risk: a population-based study. Neurology. 2019;93(5):e424-e432. doi:10.1212/WNL.0000000000007861</Citation><ArticleIdList><ArticleId IdType="doi">10.1212/WNL.0000000000007861</ArticleId><ArticleId IdType="pubmed">31243073</ArticleId></ArticleIdList></Reference><Reference><Citation>Yu Y, Su FC, Callaghan BC, Goutman SA, Batterman SA, Feldman EL. Environmental risk factors and amyotrophic lateral sclerosis (ALS): a case-control study of ALS in Michigan. PLoS One. 2014;9(6):e101186. doi:10.1371/journal.pone.0101186</Citation><ArticleIdList><ArticleId IdType="doi">10.1371/journal.pone.0101186</ArticleId><ArticleId IdType="pmc">PMC4076303</ArticleId><ArticleId IdType="pubmed">24979055</ArticleId></ArticleIdList></Reference><Reference><Citation>Visser AE, Rooney JPK, D&#x2019;Ovidio F, et al. ; Euro-MOTOR consortium . Multicentre, cross-cultural, population-based, case-control study of physical activity as risk factor for amyotrophic lateral sclerosis. J Neurol Neurosurg Psychiatry. 2018;89(8):797-803. doi:10.1136/jnnp-2017-317724</Citation><ArticleIdList><ArticleId IdType="doi">10.1136/jnnp-2017-317724</ArticleId><ArticleId IdType="pubmed">29685899</ArticleId></ArticleIdList></Reference><Reference><Citation>Wu P-F, Lu H, Zhou X, et al. . Assessment of causal effects of physical activity on neurodegenerative diseases: a mendelian randomization study. J Sport Health Sci. 2021;10(4):454-461. doi:10.1016/j.jshs.2021.01.008</Citation><ArticleIdList><ArticleId IdType="doi">10.1016/j.jshs.2021.01.008</ArticleId><ArticleId IdType="pmc">PMC8343066</ArticleId><ArticleId IdType="pubmed">33515719</ArticleId></ArticleIdList></Reference><Reference><Citation>Canosa A, D&#x2019;Ovidio F, Calvo A, et al. . Lifetime sport practice and brain metabolism in amyotrophic lateral sclerosis. Neuroimage Clin. 2020;27:102312. doi:10.1016/j.nicl.2020.102312</Citation><ArticleIdList><ArticleId IdType="doi">10.1016/j.nicl.2020.102312</ArticleId><ArticleId IdType="pmc">PMC7334468</ArticleId><ArticleId IdType="pubmed">32622315</ArticleId></ArticleIdList></Reference><Reference><Citation>Palmer P, Pullis K, Lahman S, Silverman M, Maher T. The ESPN Pro Football Encyclopedia. Sterling Publishing Co; 2007.</Citation></Reference><Reference><Citation>Kmush BL, Mackowski M, Ehrlich J, Walia B, Owora A, Sanders S. Association of professional football cumulative head impact index scores with all-cause mortality among National Football League players. JAMA Netw Open. 2020;3(5):e204442. doi:10.1001/jamanetworkopen.2020.4442</Citation><ArticleIdList><ArticleId IdType="doi">10.1001/jamanetworkopen.2020.4442</ArticleId><ArticleId IdType="pmc">PMC7215260</ArticleId><ArticleId IdType="pubmed">32391891</ArticleId></ArticleIdList></Reference><Reference><Citation>Mez J, Daneshvar DH, Kiernan PT, et al. Clinicopathological evaluation of chronic traumatic encephalopathy in players of American football. JAMA. 2017;318(4):360-370. doi:10.1001/jama.2017.8334</Citation><ArticleIdList><ArticleId IdType="doi">10.1001/jama.2017.8334</ArticleId><ArticleId IdType="pmc">PMC5807097</ArticleId><ArticleId IdType="pubmed">28742910</ArticleId></ArticleIdList></Reference><Reference><Citation>State of California, Department of Finance. State and county population projections 2010-2060. Accessed April 27, 2021. https://www.dof.ca.gov/Forecasting/Demographics/Projections/</Citation></Reference><Reference><Citation>Centers for Disease Control and Prevention . Life Table Analysis System&#x2014;rate file information. Accessed April 6, 2021. https://www.cdc.gov/niosh/ltas/rates.html</Citation></Reference><Reference><Citation>BrownGreer PLC . NFL concussion settlement program summary report. Accessed April 5, 2021. https://www.nflconcussionsettlement.com/Docs/3_29_21_report.pdf</Citation></Reference><Reference><Citation>Lapchick R. The 2019 racial and gender report card: National Football League. The Institute for Diversity and Ethics in Sport. October 30, 2019. Accessed April 19, 2021. https://43530132-36e9-4f52-811a-182c7a91933b.filesusr.com/ugd/3844fb_1478b405e58e42608f1ed2223437d398.pdf</Citation></Reference><Reference><Citation>Zeegers M. History of the NFL helmet. Sportscasting. Accessed April 19, 2021. https://www.sportscasting.com/history-of-the-nfl-helmet/</Citation></Reference><Reference><Citation>Daneshvar DH, Baugh CM, Nowinski CJ, McKee AC, Stern RA, Cantu RC. Helmets and mouth guards: the role of personal equipment in preventing sport-related concussions. Clin Sports Med. 2011;30(1):145-163, x. doi:10.1016/j.csm.2010.09.006</Citation><ArticleIdList><ArticleId IdType="doi">10.1016/j.csm.2010.09.006</ArticleId><ArticleId IdType="pmc">PMC2987604</ArticleId><ArticleId IdType="pubmed">21074089</ArticleId></ArticleIdList></Reference><Reference><Citation>Mez J, Daneshvar DH, Abdolmohammadi B, et al. . Duration of American football play and chronic traumatic encephalopathy. Ann Neurol. 2020;87(1):116-131. doi:10.1002/ana.25611</Citation><ArticleIdList><ArticleId IdType="doi">10.1002/ana.25611</ArticleId><ArticleId IdType="pmc">PMC6973077</ArticleId><ArticleId IdType="pubmed">31589352</ArticleId></ArticleIdList></Reference><Reference><Citation>McKee AC, Stern RA, Nowinski CJ, et al. . The spectrum of disease in chronic traumatic encephalopathy. Brain. 2013;136(pt 1):43-64. doi:10.1093/brain/aws307</Citation><ArticleIdList><ArticleId IdType="doi">10.1093/brain/aws307</ArticleId><ArticleId IdType="pmc">PMC3624697</ArticleId><ArticleId IdType="pubmed">23208308</ArticleId></ArticleIdList></Reference><Reference><Citation>Daneshvar DH, Riley DO, Nowinski CJ, McKee AC, Stern RA, Cantu RC. Long-term consequences: effects on normal development profile after concussion. Phys Med Rehabil Clin N Am. 2011;22(4):683-700, ix. doi:10.1016/j.pmr.2011.08.009</Citation><ArticleIdList><ArticleId IdType="doi">10.1016/j.pmr.2011.08.009</ArticleId><ArticleId IdType="pmc">PMC3208826</ArticleId><ArticleId IdType="pubmed">22050943</ArticleId></ArticleIdList></Reference><Reference><Citation>Harwood CA, McDermott CJ, Shaw PJ. Physical activity as an exogenous risk factor in motor neuron disease (MND): a review of the evidence. Amyotroph Lateral Scler. 2009;10(4):191-204. doi:10.1080/17482960802549739</Citation><ArticleIdList><ArticleId IdType="doi">10.1080/17482960802549739</ArticleId><ArticleId IdType="pubmed">19263258</ArticleId></ArticleIdList></Reference><Reference><Citation>Peters S, Visser AE, D&#x2019;Ovidio F, et al. ; Euro-MOTOR consortium . Effect modification of the association between total cigarette smoking and ALS risk by intensity, duration and time-since-quitting: Euro-MOTOR. J Neurol Neurosurg Psychiatry. 2020;91(1):33-39. doi:10.1136/jnnp-2019-320986</Citation><ArticleIdList><ArticleId IdType="doi">10.1136/jnnp-2019-320986</ArticleId><ArticleId IdType="pubmed">31434759</ArticleId></ArticleIdList></Reference><Reference><Citation>Cronin S, Hardiman O, Traynor BJ. Ethnic variation in the incidence of ALS: a systematic review. Neurology. 2007;68(13):1002-1007. doi:10.1212/01.wnl.0000258551.96893.6f</Citation><ArticleIdList><ArticleId IdType="doi">10.1212/01.wnl.0000258551.96893.6f</ArticleId><ArticleId IdType="pubmed">17389304</ArticleId></ArticleIdList></Reference><Reference><Citation>Alosco ML, Kasimis AB, Stamm JM, et al. . Age of first exposure to American football and long-term neuropsychiatric and cognitive outcomes. Transl Psychiatry. 2017;7(9):e1236. doi:10.1038/tp.2017.197</Citation><ArticleIdList><ArticleId IdType="doi">10.1038/tp.2017.197</ArticleId><ArticleId IdType="pmc">PMC5639242</ArticleId><ArticleId IdType="pubmed">28926003</ArticleId></ArticleIdList></Reference><Reference><Citation>Alosco ML, Mez J, Tripodis Y, et al. . Age of first exposure to tackle football and chronic traumatic encephalopathy. Ann Neurol. 2018;83(5):886-901. doi:10.1002/ana.25245</Citation><ArticleIdList><ArticleId IdType="doi">10.1002/ana.25245</ArticleId><ArticleId IdType="pmc">PMC6367933</ArticleId><ArticleId IdType="pubmed">29710395</ArticleId></ArticleIdList></Reference><Reference><Citation>Daneshvar DH, Goldstein LE, Kiernan PT, Stein TD, McKee AC. Post-traumatic neurodegeneration and chronic traumatic encephalopathy. Mol Cell Neurosci. 2015;66(Pt B):81-90. doi:10.1016/j.mcn.2015.03.007</Citation><ArticleIdList><ArticleId IdType="doi">10.1016/j.mcn.2015.03.007</ArticleId><ArticleId IdType="pubmed">25758552</ArticleId></ArticleIdList></Reference><Reference><Citation>McKee AC, Daneshvar DH, Alvarez VE, Stein TD. The neuropathology of sport. Acta Neuropathol. 2014;127(1):29-51. doi:10.1007/s00401-013-1230-6</Citation><ArticleIdList><ArticleId IdType="doi">10.1007/s00401-013-1230-6</ArticleId><ArticleId IdType="pmc">PMC4255282</ArticleId><ArticleId IdType="pubmed">24366527</ArticleId></ArticleIdList></Reference><Reference><Citation>Blecher R, Elliott MA, Yilmaz E, et al. . Contact sports as a risk factor for amyotrophic lateral sclerosis: a systematic review. Global Spine J. 2019;9(1):104-118. doi:10.1177/2192568218813916</Citation><ArticleIdList><ArticleId IdType="doi">10.1177/2192568218813916</ArticleId><ArticleId IdType="pmc">PMC6362556</ArticleId><ArticleId IdType="pubmed">30775214</ArticleId></ArticleIdList></Reference><Reference><Citation>Seals RM, Kioumourtzoglou MA, Hansen J, Gredal O, Weisskopf MG. Amyotrophic lateral sclerosis and the military: a population-based study in the Danish registries. Epidemiology. 2016;27(2):188-193. doi:10.1097/EDE.0000000000000417</Citation><ArticleIdList><ArticleId IdType="doi">10.1097/EDE.0000000000000417</ArticleId><ArticleId IdType="pmc">PMC5119482</ArticleId><ArticleId IdType="pubmed">26583610</ArticleId></ArticleIdList></Reference><Reference><Citation>Bandres-Ciga S, Noyce AJ, Hemani G, et al. ; ITALSGEN Consortium; International ALS Genomics Consortium . Shared polygenic risk and causal inferences in amyotrophic lateral sclerosis. Ann Neurol. 2019;85(4):470-481. doi:10.1002/ana.25431</Citation><ArticleIdList><ArticleId IdType="doi">10.1002/ana.25431</ArticleId><ArticleId IdType="pmc">PMC6450729</ArticleId><ArticleId IdType="pubmed">30723964</ArticleId></ArticleIdList></Reference></ReferenceList></PubmedData></PubmedArticle></PubmedArticleSet>